White House Reviews Final Rule Requiring Price Disclosure In Drug Ads

By John Wilkerson
March 21, 2019 at 1:35 PM
The White House budget office is reviewing the final version of CMS’ proposal to require that television drug advertisements disclose prices, according to the Office of Management and Budget website. In October, HHS proposed forcing drug makers to disclose list prices for drugs that Medicare and Medicaid purchase. The administration’s plan would rely on companies to sue each other for violations, which some doubt would happen, and industry is expected to take the agency to court over the rule. Congressional...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.